CVRF
Clinical Research Coordinating Center(CRCC)
Data Management
Core Laboratories
Translational Research
Research Activity
Paper Publication
Translational Research
Cheol Whan Lee, MD, PhD
To improve human health, scientific discoveries must be translated into practical applications. Such discoveries typically begin at “the bench” with basic research - in which scientists study disease at a molecular or cellular level - then progress to the clinical level, or the patient's “bedside” Scientists are increasingly aware that this bench-to-bedside approach to translational research is really a two-way street. Basic scientists provide clinicians with new tools for use in patients and for assessment of their impact, and clinical researchers make novel observations about the nature and progression of disease that often stimulate basic investigations.

The CVRF's Translational Research has established to encourage and provide support for novel translational cardiovascular research. Physicians and scientists play a crucial role in the continuum of cardiovascular research that brings together the progress in the laboratory and the progress in the clinic. The Translational Research demands an intense interaction between investigators with diverse backgrounds. Our Translational Research will accelerate the pace of cardiovascular research in the early stages of translation to the clinical setting and transfer of findings from the laboratory to clinical application. The purpose of this program is to support research that shows high promise for translating basic biomedical knowledge to diagnosis or new treatments and, ultimately, to prolong and enhance life in the field of cardiovascular disease. The CVRF's Translational Research also supports activities that impact the environment in which translational research is conducted.

The translational research of CVRF depends heavily on innovative new technologies to overcome the limitation of current devices in interventional cardiology. In particular, because of an apparent paradox of the current drug-eluting stent, which slightly increases the incidence of late thrombosis, the development of the new drug-eluting stent has been highlighted in our translational research. We developed a successful system of a new drug-eluting stent to reduce the rate of restenosis even further and to abolish the risk of thrombosis. The new drug-eluting stent is a unique in that a combination of drugs is incorporated into a proprietary polymer. We also support the human clinical trials assessing the outcomes of new coronary devices.
Home About CVRF
Mission
Board Members
Management Team
CVRF Brochure
The Heart Beat
Research
Clinical Research Coordinating Center(CRCC)
- Data Management
- Core Laboratories
Translational Research
Research Activity
Paper Publication
Conference
TCTAP
AP VALVES
Complex PCI
Education
www.summitMD.com
Publication
ACT Program
Fellowship Training Program
- The Short-term Training Program
- The Long-term Training Program
- IVUS Fellowship Program
Fundraising
CVRF YoutubeFacebook